APR-246 enhances the anticancer effect of doxorubicin against p53-mutant AsPC-1 pancreatic cancer cells. Baghdad Science Journal, Iraq, Baghdad, v. 21, n. 8, p. 2551, 2024. DOI: 10.21123/bsj.2024.10135. Disponível em: https://bsj.uobaghdad.edu.iq/index.php/BSJ/article/view/10135.. Acesso em: 22 dec. 2024.